Dr. Robert Travis Neff, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 419 S Washington St, Suite 102, Casper, WY 82601 Phone: 307-237-5047 Fax: 307-235-4017 |
Dr. Eric Sawyers, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 419 S Washington St Ste 102a, Casper, WY 82601 Phone: 307-237-5047 Fax: 307-235-4017 |
Jean A Halpern, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2301 House Ave, Ste 201, Cheyenne, WY 82001 Phone: 307-635-9131 Fax: 307-637-8300 |
Ageselaos John Meares, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1760 Prairie Ave Ste 100, Cheyenne, WY 82009 Phone: 307-263-4022 Fax: 307-263-4023 |
Dr. Timothy C Govaerts, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1760 Prairie Ave Ste 100, Cheyenne, WY 82009 Phone: 307-263-4022 Fax: 307-263-4023 |
Robert Neuwirth, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 501 S. Burma Ave, Gillette, WY 82716 Phone: 307-688-3535 Fax: 307-688-3528 |
Dr. Rahul N Pawar, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1180 College Dr, Rock Springs, WY 82901 Phone: 307-212-7711 Fax: 307-352-8210 |
News Archive
An artificial intelligence device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity.
Researchers at the University of São Paulo in Brazil have discovered that growth hormone (GH), which stimulates skeletal maturation and linear bone growth, as well as helping maintain tissue and organs throughout life, also acts directly on the brain to conserve energy when the body loses weight.
UT Southwestern Medical Center heart specialists will study whether electrocardiograms (ECGs) are useful in identifying Texas high school student athletes who are at risk of suffering sudden cardiac death.
Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, today announced the close of a Series B financing totaling $20 million. The round was led by new investor Domain Associates, LLC, which was joined by existing investors including CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.
› Verified 8 days ago